Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancer
This study has been terminated.
Sponsor:
Transgene
Collaborators:
University of California, Los Angeles
The Cleveland Clinic
University of Arizona
Information provided by:
Transgene
ClinicalTrials.gov Identifier:
NCT00040170
First received: June 21, 2002
Last updated: October 31, 2006
Last verified: October 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |